Parâmetros de segurança e funcionalidade de bactérias bífidas isoladas de recém-nascidos, com indicação de uso como probiótico em bancos de leite humano

Detalhes bibliográficos
Ano de defesa: 2006
Autor(a) principal: Cunha, Luciana Rodrigues da
Orientador(a): Ferreira, Célia Lúcia de Luces Fortes lattes
Banca de defesa: Carvalho, Antônio Fernandes de lattes, Maldonado, Izabel Regina dos Santos Costa lattes, Ribeiro Junior, José Ivo lattes, Costa, Neuza Maria Brunoro lattes
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Viçosa
Programa de Pós-Graduação: Mestrado em Ciência e Tecnologia de Alimentos
Departamento: Ciência de Alimentos; Tecnologia de Alimentos; Engenharia de Alimentos
País: BR
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://locus.ufv.br/handle/123456789/2957
Resumo: The objective of this study was to evaluate some parameters of security and functionality currently recommended for validation of probiotics. The parameters evaluated were antimicrobial susceptibility, antagonism to the growth of pathogens, oral chronic toxicity and bacterial translocation of new lineages of Bifidobacterium breve isolated from newborn, with potential of use as probiotics in human milk banks. The experiments were divided in three parts. In the first one, the susceptibility of 31 lineages of Bifidobacterium breve to the most common antimicrobials (14) used in UTIneonatal from Brazilian institutions was evaluated. In the second part, the antagonism to the growth of lineages of Clostridium difficile, Salmonella typhimurium, Escherichia coli, Listeria monocytogenes and Staphylococcus aureus was evaluated using the "spot" technique and plate diffusion. To exclude the effect of organic acid inhibition, the spot test was also performed in buffered sodium bicarbonate medium. Based in the results found in the test of antibiotics sensitivity and in those of resistance to bile salts and gastric juice from previous studies, seven lineages were selected to compose the pool of probiotics that was used for verification of the oral chronic toxicity and bacterial translocation, in the third phase of the experiment, in which it was used for each replication 16 wearing Wistar rats with 21-23 days of life, were divided in 4 groups: Basal, Control, LP (pasteurized human milk) and LPB (pasteurized human milk containing bifid bacterium). The four animals that composed the basal group were sacrificed in the first day of the experiment (T0) while the others were fed with different diets during 21 days and sacrificed later. Liver, kidneys, heart, and spleen were removed, weighed and tested for oral chronic toxicity and bacterial translocation. The experiment was conducted in three repetitions. It was found that the 31 lineages of Bifidobacterium breve were resistant to antimicrobial ciprofloxacin, amicacin and gentamicin, among the 14 antibiotics evaluated. For the other antimicrobials, sensitivity varied from 2% (sulfonamide) to 100% (vancomycin, amoxicillin, ampicillin and penicillin). These same isolated varied in the antagonistic activity on the growth of the different pathogens evaluated by the "spot" method. This inhibition was lineage-dependent and not only promoted by organic acids, as it was not totally reverted in the buffered medium. The supernatant free of bifid bacteria cells did not promote inhibition of the pathogens evaluated. It was verified that the selected lineages of Bifidobacterium breve (UFVCC 1083, 1091, 1099, 1103, 1105, 1108 and 1111) did not promote adverse effect in the animal health. Similarly, they did not induce oral chronic toxicity or translocation of bacteria of the gastrointestinal tract to the liver, kidneys, heart and spleen after 21 days of experimentation.
id UFV_cd7e1543635e2b94161cf83d962409b0
oai_identifier_str oai:locus.ufv.br:123456789/2957
network_acronym_str UFV
network_name_str LOCUS Repositório Institucional da UFV
repository_id_str
spelling Cunha, Luciana Rodrigues dahttp://lattes.cnpq.br/3546793877060403Ferreira, Célia Lúcia de Luces Forteshttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4793681U9Carvalho, Antônio Fernandes dehttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4781655T2Maldonado, Izabel Regina dos Santos Costahttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4780778U6Ribeiro Junior, José Ivohttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4723282Y6Costa, Neuza Maria Brunorohttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4781709D62015-03-26T13:13:33Z2006-11-082015-03-26T13:13:33Z2006-05-05CUNHA, Luciana Rodrigues da. Parameters of security and functionality of the Bifidobacterium isolated from newborn, with potential of use as probiotics in human milk banks. 2006. 40 f. Dissertação (Mestrado em Ciência de Alimentos; Tecnologia de Alimentos; Engenharia de Alimentos) - Universidade Federal de Viçosa, Viçosa, 2006.http://locus.ufv.br/handle/123456789/2957The objective of this study was to evaluate some parameters of security and functionality currently recommended for validation of probiotics. The parameters evaluated were antimicrobial susceptibility, antagonism to the growth of pathogens, oral chronic toxicity and bacterial translocation of new lineages of Bifidobacterium breve isolated from newborn, with potential of use as probiotics in human milk banks. The experiments were divided in three parts. In the first one, the susceptibility of 31 lineages of Bifidobacterium breve to the most common antimicrobials (14) used in UTIneonatal from Brazilian institutions was evaluated. In the second part, the antagonism to the growth of lineages of Clostridium difficile, Salmonella typhimurium, Escherichia coli, Listeria monocytogenes and Staphylococcus aureus was evaluated using the "spot" technique and plate diffusion. To exclude the effect of organic acid inhibition, the spot test was also performed in buffered sodium bicarbonate medium. Based in the results found in the test of antibiotics sensitivity and in those of resistance to bile salts and gastric juice from previous studies, seven lineages were selected to compose the pool of probiotics that was used for verification of the oral chronic toxicity and bacterial translocation, in the third phase of the experiment, in which it was used for each replication 16 wearing Wistar rats with 21-23 days of life, were divided in 4 groups: Basal, Control, LP (pasteurized human milk) and LPB (pasteurized human milk containing bifid bacterium). The four animals that composed the basal group were sacrificed in the first day of the experiment (T0) while the others were fed with different diets during 21 days and sacrificed later. Liver, kidneys, heart, and spleen were removed, weighed and tested for oral chronic toxicity and bacterial translocation. The experiment was conducted in three repetitions. It was found that the 31 lineages of Bifidobacterium breve were resistant to antimicrobial ciprofloxacin, amicacin and gentamicin, among the 14 antibiotics evaluated. For the other antimicrobials, sensitivity varied from 2% (sulfonamide) to 100% (vancomycin, amoxicillin, ampicillin and penicillin). These same isolated varied in the antagonistic activity on the growth of the different pathogens evaluated by the "spot" method. This inhibition was lineage-dependent and not only promoted by organic acids, as it was not totally reverted in the buffered medium. The supernatant free of bifid bacteria cells did not promote inhibition of the pathogens evaluated. It was verified that the selected lineages of Bifidobacterium breve (UFVCC 1083, 1091, 1099, 1103, 1105, 1108 and 1111) did not promote adverse effect in the animal health. Similarly, they did not induce oral chronic toxicity or translocation of bacteria of the gastrointestinal tract to the liver, kidneys, heart and spleen after 21 days of experimentation.O objetivo desse trabalho foi avaliar alguns parâmetros de segurança e funcionalidade atualmente recomendados para validação de novas estirpes de Bifidobacterium breve, isoladas de recém nascidos com potencial de uso como probiótico em bancos de leite humano. Foram avaliados susceptibilidade antimicrobiana, antagonismo a patógenos, toxicidade oral crônica e translocação bacteriana. A experimentação foi dividida em três fases. Na primeira, avaliou-se a susceptibilidade de 31 estirpes de Bifidobacterium breve aos principais antimicrobianos (14) utilizados em UTIneonatal nas instituições brasileiras. Na segunda fase, avaliou-se o antagonismo das estirpes sobre o crescimento de Clostridium difficile, Salmonella typhimurium, Escherichia coli, Listeria monocytogenes e Staphylococcus aureus, utilizando-se a técnica spot e difusão em placas. Para excluir o efeito inibitório dos ácidos orgânicos realizou-se também o teste spot em meio tamponado com bicarbonato de sódio. Baseado nos resultados encontrados no teste de sensibilidade a antibióticos e naqueles de resistência a sais biliares e suco gástrico obtidos em estudos anteriores, foram selecionadas sete estirpes para comporem o pool probióticos que foi utilizado para verificação da toxicidade oral crônica e translocação bacteriana, na terceira fase do experimento, na qual empregou-se em cada repetição, 16 ratas Wistar com 21 a 23 dias de vida, recém desmamadas, que foram divididas em quatro grupos por unidade experimental: Basal, Controle, LP (Leite humano pasteurizado) e LPB (leite humano pasteurizado acrescido de bacterias bífidas). Os quatro animais que compuseram o grupo basal foram sacrificados no primeiro dia da experimentação (T0) e aqueles dos outros grupos foram alimentados diariamente (0,1 mL) via oral com auxílio de micropipeta esterilizada com diferentes dietas, durante 21 dias e posteriormente sacrificados. Fígado, rins, coração e baço, foram removidos, pesados e testados para verificação da toxicidade oral crônica e translocação bacteriana. O experimento foi realizado em três repetições. Verificou-se que as 31 estirpes de Bifidobacterium breve foram resistentes aos antimicrobianos ciprofloxacina, amicacina e gentamicina, dentre os 14 antibióticos avaliados. Para os outros antimicrobianos, a sensibilidade variou de 2% (sulfonamida) a 100% (vancomicina, amoxicilina, ampicilina e penicilina). Esses mesmos isolados apresentaram variabilidade na atividade antagonística sobre o crescimento dos diferentes patógenos avaliados pelo método spot . Esssa inibição foi estirpe dependente e não promovida somente por ácidos orgânicos, uma vez que não foi totalmente revertida quando utilizou-se meio tamponado. O sobrenadante livre de células de bactérias bífidas não promoveu inibição dos patógenos avaliados. Verificou-se que as estirpes de Bifidobacterium breve selecionadas (UFVCC 1083, 1091, 1099, 1103, 1105, 1108 e 1111) não promoveram efeito adverso na saúde dos animais testados, uma vez que não induziram toxicidade oral crônica e nem translocação de bactérias do trato gastrointestinal para o fígado, rins coração e baço após os 21 dias da experimentação. No entanto, sugere-se a realização dos mesmos testes aqui avaliados com outros mamíferos, como coelhos, macacos e humanos para confirmar a segurança de uso desses isolados.Universidade Federal de Ouro Pretoapplication/pdfporUniversidade Federal de ViçosaMestrado em Ciência e Tecnologia de AlimentosUFVBRCiência de Alimentos; Tecnologia de Alimentos; Engenharia de AlimentosSusceptibilidade antimicrobianaAtividade antagonistaTranslocação bacterianaToxicidade oral crônicaProbióticoAntimicrobial susceptibilityAntagonism activityBacterial translocationOral chronic toxicityProbioticsCNPQ::CIENCIAS AGRARIAS::CIENCIA E TECNOLOGIA DE ALIMENTOS::CIENCIA DE ALIMENTOSParâmetros de segurança e funcionalidade de bactérias bífidas isoladas de recém-nascidos, com indicação de uso como probiótico em bancos de leite humanoParameters of security and functionality of the Bifidobacterium isolated from newborn, with potential of use as probiotics in human milk banksinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:LOCUS Repositório Institucional da UFVinstname:Universidade Federal de Viçosa (UFV)instacron:UFVORIGINAL01 - capa_introducao.pdfapplication/pdf47047https://locus.ufv.br//bitstream/123456789/2957/1/01%20-%20capa_introducao.pdf9b033e29a85d79137a8675aecdd850f5MD5102 - conclusao_referencias bibliograficas.pdf02 - conclusao_referencias bibliograficas.pdfapplication/pdf70220https://locus.ufv.br//bitstream/123456789/2957/2/02%20-%20conclusao_referencias%20bibliograficas.pdfbdcf687df277cf5b2b5934318afc7796MD52TEXT01 - capa_introducao.pdf.txt01 - capa_introducao.pdf.txtExtracted texttext/plain33168https://locus.ufv.br//bitstream/123456789/2957/3/01%20-%20capa_introducao.pdf.txt3213b7f5da89b2e403527d2b4e54c189MD5302 - conclusao_referencias bibliograficas.pdf.txt02 - conclusao_referencias bibliograficas.pdf.txtExtracted texttext/plain40785https://locus.ufv.br//bitstream/123456789/2957/4/02%20-%20conclusao_referencias%20bibliograficas.pdf.txt7efc145cf4cdaf3d51206226803ff56bMD54THUMBNAIL01 - capa_introducao.pdf.jpg01 - capa_introducao.pdf.jpgIM Thumbnailimage/jpeg3817https://locus.ufv.br//bitstream/123456789/2957/5/01%20-%20capa_introducao.pdf.jpg2442a1af4da490e377363e394159a603MD5502 - conclusao_referencias bibliograficas.pdf.jpg02 - conclusao_referencias bibliograficas.pdf.jpgIM Thumbnailimage/jpeg3781https://locus.ufv.br//bitstream/123456789/2957/6/02%20-%20conclusao_referencias%20bibliograficas.pdf.jpg235050f3f723539bae1847f8d81ff292MD56123456789/29572016-04-08 23:20:48.827oai:locus.ufv.br:123456789/2957Repositório InstitucionalPUBhttps://www.locus.ufv.br/oai/requestfabiojreis@ufv.bropendoar:21452016-04-09T02:20:48LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV)false
dc.title.por.fl_str_mv Parâmetros de segurança e funcionalidade de bactérias bífidas isoladas de recém-nascidos, com indicação de uso como probiótico em bancos de leite humano
dc.title.alternative.eng.fl_str_mv Parameters of security and functionality of the Bifidobacterium isolated from newborn, with potential of use as probiotics in human milk banks
title Parâmetros de segurança e funcionalidade de bactérias bífidas isoladas de recém-nascidos, com indicação de uso como probiótico em bancos de leite humano
spellingShingle Parâmetros de segurança e funcionalidade de bactérias bífidas isoladas de recém-nascidos, com indicação de uso como probiótico em bancos de leite humano
Cunha, Luciana Rodrigues da
Susceptibilidade antimicrobiana
Atividade antagonista
Translocação bacteriana
Toxicidade oral crônica
Probiótico
Antimicrobial susceptibility
Antagonism activity
Bacterial translocation
Oral chronic toxicity
Probiotics
CNPQ::CIENCIAS AGRARIAS::CIENCIA E TECNOLOGIA DE ALIMENTOS::CIENCIA DE ALIMENTOS
title_short Parâmetros de segurança e funcionalidade de bactérias bífidas isoladas de recém-nascidos, com indicação de uso como probiótico em bancos de leite humano
title_full Parâmetros de segurança e funcionalidade de bactérias bífidas isoladas de recém-nascidos, com indicação de uso como probiótico em bancos de leite humano
title_fullStr Parâmetros de segurança e funcionalidade de bactérias bífidas isoladas de recém-nascidos, com indicação de uso como probiótico em bancos de leite humano
title_full_unstemmed Parâmetros de segurança e funcionalidade de bactérias bífidas isoladas de recém-nascidos, com indicação de uso como probiótico em bancos de leite humano
title_sort Parâmetros de segurança e funcionalidade de bactérias bífidas isoladas de recém-nascidos, com indicação de uso como probiótico em bancos de leite humano
author Cunha, Luciana Rodrigues da
author_facet Cunha, Luciana Rodrigues da
author_role author
dc.contributor.authorLattes.por.fl_str_mv http://lattes.cnpq.br/3546793877060403
dc.contributor.author.fl_str_mv Cunha, Luciana Rodrigues da
dc.contributor.advisor1.fl_str_mv Ferreira, Célia Lúcia de Luces Fortes
dc.contributor.advisor1Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4793681U9
dc.contributor.referee1.fl_str_mv Carvalho, Antônio Fernandes de
dc.contributor.referee1Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4781655T2
dc.contributor.referee2.fl_str_mv Maldonado, Izabel Regina dos Santos Costa
dc.contributor.referee2Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4780778U6
dc.contributor.referee3.fl_str_mv Ribeiro Junior, José Ivo
dc.contributor.referee3Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4723282Y6
dc.contributor.referee4.fl_str_mv Costa, Neuza Maria Brunoro
dc.contributor.referee4Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4781709D6
contributor_str_mv Ferreira, Célia Lúcia de Luces Fortes
Carvalho, Antônio Fernandes de
Maldonado, Izabel Regina dos Santos Costa
Ribeiro Junior, José Ivo
Costa, Neuza Maria Brunoro
dc.subject.por.fl_str_mv Susceptibilidade antimicrobiana
Atividade antagonista
Translocação bacteriana
Toxicidade oral crônica
Probiótico
topic Susceptibilidade antimicrobiana
Atividade antagonista
Translocação bacteriana
Toxicidade oral crônica
Probiótico
Antimicrobial susceptibility
Antagonism activity
Bacterial translocation
Oral chronic toxicity
Probiotics
CNPQ::CIENCIAS AGRARIAS::CIENCIA E TECNOLOGIA DE ALIMENTOS::CIENCIA DE ALIMENTOS
dc.subject.eng.fl_str_mv Antimicrobial susceptibility
Antagonism activity
Bacterial translocation
Oral chronic toxicity
Probiotics
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS AGRARIAS::CIENCIA E TECNOLOGIA DE ALIMENTOS::CIENCIA DE ALIMENTOS
description The objective of this study was to evaluate some parameters of security and functionality currently recommended for validation of probiotics. The parameters evaluated were antimicrobial susceptibility, antagonism to the growth of pathogens, oral chronic toxicity and bacterial translocation of new lineages of Bifidobacterium breve isolated from newborn, with potential of use as probiotics in human milk banks. The experiments were divided in three parts. In the first one, the susceptibility of 31 lineages of Bifidobacterium breve to the most common antimicrobials (14) used in UTIneonatal from Brazilian institutions was evaluated. In the second part, the antagonism to the growth of lineages of Clostridium difficile, Salmonella typhimurium, Escherichia coli, Listeria monocytogenes and Staphylococcus aureus was evaluated using the "spot" technique and plate diffusion. To exclude the effect of organic acid inhibition, the spot test was also performed in buffered sodium bicarbonate medium. Based in the results found in the test of antibiotics sensitivity and in those of resistance to bile salts and gastric juice from previous studies, seven lineages were selected to compose the pool of probiotics that was used for verification of the oral chronic toxicity and bacterial translocation, in the third phase of the experiment, in which it was used for each replication 16 wearing Wistar rats with 21-23 days of life, were divided in 4 groups: Basal, Control, LP (pasteurized human milk) and LPB (pasteurized human milk containing bifid bacterium). The four animals that composed the basal group were sacrificed in the first day of the experiment (T0) while the others were fed with different diets during 21 days and sacrificed later. Liver, kidneys, heart, and spleen were removed, weighed and tested for oral chronic toxicity and bacterial translocation. The experiment was conducted in three repetitions. It was found that the 31 lineages of Bifidobacterium breve were resistant to antimicrobial ciprofloxacin, amicacin and gentamicin, among the 14 antibiotics evaluated. For the other antimicrobials, sensitivity varied from 2% (sulfonamide) to 100% (vancomycin, amoxicillin, ampicillin and penicillin). These same isolated varied in the antagonistic activity on the growth of the different pathogens evaluated by the "spot" method. This inhibition was lineage-dependent and not only promoted by organic acids, as it was not totally reverted in the buffered medium. The supernatant free of bifid bacteria cells did not promote inhibition of the pathogens evaluated. It was verified that the selected lineages of Bifidobacterium breve (UFVCC 1083, 1091, 1099, 1103, 1105, 1108 and 1111) did not promote adverse effect in the animal health. Similarly, they did not induce oral chronic toxicity or translocation of bacteria of the gastrointestinal tract to the liver, kidneys, heart and spleen after 21 days of experimentation.
publishDate 2006
dc.date.available.fl_str_mv 2006-11-08
2015-03-26T13:13:33Z
dc.date.issued.fl_str_mv 2006-05-05
dc.date.accessioned.fl_str_mv 2015-03-26T13:13:33Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv CUNHA, Luciana Rodrigues da. Parameters of security and functionality of the Bifidobacterium isolated from newborn, with potential of use as probiotics in human milk banks. 2006. 40 f. Dissertação (Mestrado em Ciência de Alimentos; Tecnologia de Alimentos; Engenharia de Alimentos) - Universidade Federal de Viçosa, Viçosa, 2006.
dc.identifier.uri.fl_str_mv http://locus.ufv.br/handle/123456789/2957
identifier_str_mv CUNHA, Luciana Rodrigues da. Parameters of security and functionality of the Bifidobacterium isolated from newborn, with potential of use as probiotics in human milk banks. 2006. 40 f. Dissertação (Mestrado em Ciência de Alimentos; Tecnologia de Alimentos; Engenharia de Alimentos) - Universidade Federal de Viçosa, Viçosa, 2006.
url http://locus.ufv.br/handle/123456789/2957
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Viçosa
dc.publisher.program.fl_str_mv Mestrado em Ciência e Tecnologia de Alimentos
dc.publisher.initials.fl_str_mv UFV
dc.publisher.country.fl_str_mv BR
dc.publisher.department.fl_str_mv Ciência de Alimentos; Tecnologia de Alimentos; Engenharia de Alimentos
publisher.none.fl_str_mv Universidade Federal de Viçosa
dc.source.none.fl_str_mv reponame:LOCUS Repositório Institucional da UFV
instname:Universidade Federal de Viçosa (UFV)
instacron:UFV
instname_str Universidade Federal de Viçosa (UFV)
instacron_str UFV
institution UFV
reponame_str LOCUS Repositório Institucional da UFV
collection LOCUS Repositório Institucional da UFV
bitstream.url.fl_str_mv https://locus.ufv.br//bitstream/123456789/2957/1/01%20-%20capa_introducao.pdf
https://locus.ufv.br//bitstream/123456789/2957/2/02%20-%20conclusao_referencias%20bibliograficas.pdf
https://locus.ufv.br//bitstream/123456789/2957/3/01%20-%20capa_introducao.pdf.txt
https://locus.ufv.br//bitstream/123456789/2957/4/02%20-%20conclusao_referencias%20bibliograficas.pdf.txt
https://locus.ufv.br//bitstream/123456789/2957/5/01%20-%20capa_introducao.pdf.jpg
https://locus.ufv.br//bitstream/123456789/2957/6/02%20-%20conclusao_referencias%20bibliograficas.pdf.jpg
bitstream.checksum.fl_str_mv 9b033e29a85d79137a8675aecdd850f5
bdcf687df277cf5b2b5934318afc7796
3213b7f5da89b2e403527d2b4e54c189
7efc145cf4cdaf3d51206226803ff56b
2442a1af4da490e377363e394159a603
235050f3f723539bae1847f8d81ff292
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV)
repository.mail.fl_str_mv fabiojreis@ufv.br
_version_ 1794528758870310912